Name: 21st International Symposium on HIV and Emerging Infectious Diseases (ISHEID 2020)
 
Organised by: European AIDS Clinical Society (EACS)
 
Venue: Palais des Papes
 
City: Avignon
 
Country: FRANCE
 
Starting Date
(dd/mm/yy):
13/05/2020
 
Ending Date
(dd/mm/yy):
15/05/2020
 
App. Nr. of HCP: 800
 
Speciality: Infectiology (Infectious diseases)
 
Website: https://isheid.com/en_GB/
 
The pre-assessment of events provided on e4EthiCS cannot, under any circumstance, be interpreted as a judgement on the quality or content of the scientific programme, or on the quality of the speakers.

It is the company’s individual decision to decide to sponsor / participate in the event. Companies belonging to the EFPIA membership should be mindful of the rules and provisions that apply when deciding to sponsor, participate or collaborate in an event.
 
EFPIA pre-assessment: (Date (dd/mm/yy): 13/11/2019)
 
Scientific Programme Schedule / Structure It is recommended to check the rules prevailing under applicable national codes.
 
Location and Venue It is recommended to check the rules prevailing under applicable national codes.
 
Hospitality Provided (Directly or Indirectly) to HCP It is recommended to check the rules prevailing under applicable national codes.
 
Other Activities Concern may arise with regard to EFPIA HCP Code provisions, for the following reasons:

Entertainment activities are organised in connection with the event.
 
Accompanying Persons Concern may arise with regard to EFPIA HCP Code provisions, for the following reasons:

Accompanying persons shall not be invited to the event or activities organised in connection with it.
 
National Code Provisions According Host Country Code of Deontology:

Drug companies should not sponsor or organize entertainment

Drug companies can only cover health professionals who are qualified to be full participants.
 
It is always recommended to check the rules prevailing under applicable national codes.

EXHIBITIONS – please read carefully the provisions of the EFPIA HCP Code and the additional guidance.
 
Latest update (dd/mm/yy): 03/12/2019